This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
STNE or INFA: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
STNE vs. INFA: Which Stock Is the Better Value Option?
AFRM Extends Partnership With Williams-Sonoma to Bring BNPL to Canada
by Zacks Equity Research
Affirm expands BNPL services to Canada through Williams-Sonoma, boosting its reach across premium brands like West Elm and Pottery Barn.
Zscaler Q3 Earnings Beat: Will Strong Guidance Lift the Stock Higher?
by Zacks Equity Research
ZS Q3 EPS beats by 12% with 23% revenue growth and raises FY25 guidance as Zero Trust and AI demand fuel 39% YTD stock surge.
Ambarella Stock Gains as Q1 Earnings Beat Estimates, Sales Rise Y/Y
by Zacks Equity Research
Ambarella's Q1 EPS beats estimates, revenues surge 58% on record Edge AI sales, lifting AMBA shares 1.6% after hours.
Zacks.com featured highlights StoneCo, Intercontinental Exchange, Southwest Gas Holdings and The Mosaic
by Zacks Equity Research
StoneCo, ICE, SWX and Mosaic show solid 2025 sales growth potential amid market uncertainty, with Zacks Ranks backing their strength.
StoneCo vs. Block: Which Fintech Stock is a Smarter Buy for 2025?
by Urmimala Biswas
STNE and XYZ drive fintech progress with distinct approaches- regional execution and product innovation- that are shaping their 2025 outlooks.
HP Stock Falls 8% on Q2 Earnings Miss, Revenues Rise Y/Y
by Zacks Equity Research
HPQ stock dips 8% after Q2 EPS misses by 11%. Despite 2.4% revenue growth, the lowered FY25 profit outlook adds to investor concerns.
Synopsys Stock Gains 4% as Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
SNPS' Q2 top-line reflects strength in EDA and other segments, while efficient cost management aids earnings growth.
4 Stocks With Solid Sales Growth to Bet on Amid Market Uncertainty
by Swayta Shah
Amid extreme market volatility and ambiguity, the traditional stock picking method ??? sales growth ??? is apt. Stocks like STNE, ICE, SWX and MOS are worth buying.
5 Valuable Price-to-Book Stocks to Strengthen Your Portfolio
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such stocks.
Semtech's Q1 Earnings Match Estimates, Revenues Increase Y/Y
by Zacks Equity Research
SMTC's Q1 earnings reflect benefits from increased revenues, operational efficiency and effective cost management.
The New York Times Company Leverages Digital Subscriptions for Growth
by Zacks Equity Research
NYT adds 11.06M digital-only subscribers in Q1, lifting digital revenues by 14.4% and boosting ARPU to $9.54, as it navigates away from declining print.
NVIDIA's Q1 Earnings to Benefit From AI and Datacenter Growth
by Zacks Equity Research
NVDA's Q1 revenues are expected to surge 64% year over year as AI demand and datacenter growth continue to drive strong performance across industries.
CRM Q1 Earnings: Will AI and Cloud Growth Outweigh Macro Challenges?
by Zacks Equity Research
Salesforce is likely to sustain growth momentum in Q1 amid rising demand for AI and cloud. However, macro headwinds and slower deal cycles may limit the upside.
Is StoneCo (STNE) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
Based on the average brokerage recommendation (ABR), StoneCo (STNE) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
Oddity Tech Soars 52% in a Month: Is the Stock Still Worth Buying?
by Zacks Equity Research
ODD gains momentum from solid revenues, expanding profitability, breakthrough product launches and successful global market expansion.
Affirm Partners With Cali Pass to Expand in a High-Spending Segment
by Zacks Equity Research
AFRM joins forces with Cali Pass, which allows skiers to split costs with flexible and transparent payment options for passes and lift tickets.
FinTech Boom Sets StoneCo on Profit Path: Time to Buy the Stock?
by Urmimala Biswas
STNE's strategic repricing initiatives and capital-return programs, including over R$2.4 billion in share buybacks over the past year, have bolstered investor confidence in the stock.
AFRM Partners With Costco and Mattress Firm for Smarter Payments
by Zacks Equity Research
Affirm joins forces with Costco and Mattress Firm to expand its reach by offering flexible and transparent pay-over-time options.
5 Low Price-to-Book Value Stocks to Buy in May
by Kinjel Shah
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and SAN are some such stocks.
STNE vs. INFA: Which Stock Is the Better Value Option?
by Zacks Equity Research
STNE vs. INFA: Which Stock Is the Better Value Option?
Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer
by Zacks Equity Research
StoneCo, Centene, CVS Health and Pfizer have been highlighted in this Screen of The Week article.
4 Value Picks to Ride the Market Rebound After US-China Trade Thaw
by Sumit Singh
Value investing is essentially about selecting stocks that are usually cheap but fundamentally sound. STNE, CNC, CVS & PFE boast a low P/CF ratio.
Earnings Estimates Rising for StoneCo (STNE): Will It Gain?
by Zacks Equity Research
StoneCo (STNE) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Brokers Suggest Investing in StoneCo (STNE): Read This Before Placing a Bet
by Zacks Equity Research
According to the average brokerage recommendation (ABR), one should invest in StoneCo (STNE). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?